Differential Transcriptional Regulation by Human Immunodeficiency Virus Type 1 and gp120 in Human Astrocytes

References

• Bouhlal H, Galon J, Kazatchkine MD, Fridman WH, Sautes-Fridman C, Haeffner Cavaillon N (2001). Soluble CD16 inhibits CR3 (CD11b/CD18)-mediated infection of monocytes/macrophages by opsonized primary R5 HIV-1. J Immuno1166: 3377–3383.
   Google Scholar
• Castedo M, Ferri KF, Blanco J, Roumier T, Larochette N, Barretina J, Amendola A, Nardacci R, Metivier D, Este JA, Piacentini M, Kroemer G (2001). Hu-man immunodeficiency virus 1 envelope glycoprotein complex-induced apoptosis involves mammalian target of rapamycin/FKBP12-rapamycin-associated protein-mediated p53 phosphorylation. J Exp Med 194: 1097–1110.
   PubMed Web of Science ®Google Scholar
• Chang TL, Mosoian A, Pine R, Klotrnan ME, Moore JP (2002). A soluble factor(s) secreted from CD8(±) T lym-phocytes inhibits human immunodeficiency virus type 1 replication through STAT1 activation. J Virol 76: 569–581.
   PubMed Web of Science ®Google Scholar
• Chen P, Mayne M, Power C, Nath A (1997). The Tat protein of HIV-1 induces tumor necrosis factor-a production: implications for HIV associated neurological diseases. J Biol Chem 272: 22385–22388.
   PubMed Web of Science ®Google Scholar
• Chiao C, Bader T, Stenger JE, Baldwin W, Brady J, Barrett JC (2001). HIV type 1 Tat inhibits tumor necrosis factor alpha-induced repression of tumor necrosis factor receptor p55 and amplifies tumor necrosis factor alpha activity in stably tat-transfected HeLa Cells. AIDS Res Hum Retroviruses 17: 1125–1132.
   PubMed Web of Science ®Google Scholar
• Cicala C, Arthos J, Selig SM, Dennis G Jr, Hosack DA, Van Ryk D, Spangler ML, Steenbeke TD, Khazanie P, Gupta N, Yang J, Daucher M, Lempicki RA, Fauci AS (2002). HIV envelope induces a cascade of cell sig-nals in non-proliferating target cells that favor virus replication. Proc Natl Acad Sci U S A 99: 9380–9385.
   PubMed Web of Science ®Google Scholar
• Corry DB, Tuck ML (2001). Selective aspects of the insulin resistance syndrome. Curr Opin Nephrol Hypertens 10: 507–514.
   Google Scholar
• Furer M, Hartloper V, Wilkins J, Nath A (1993). Lymphocyte emperipolesis in human glial cells. Cell Adhes Commun 1: 223–237.
   Web of Science ®Google Scholar
• Geiss GK, Bumgamer RE, An MC, Agy MB, van't Wout AB, Ha=ersmark E, Carter VS, Upchurch D, Mullins JI, Katze MG (2000). Large-scale monitoring of host cell gene expression during HIV-1 infection using cDNA mi-croarrays. Virology 266: 8–16.
   PubMed Web of Science ®Google Scholar
• Gekker G, Lokensgard JR, Peterson PK (2001). Naltrexone potentiates anti-HIV-1 activity of antiretroviral drugs in CD4(±) lymphocyte cultures. Drug Alcohol Depend 64: 257–263.
   PubMed Web of Science ®Google Scholar
• Gurwell JA, Nath A, Sun Q, Zhang J, Martin KM, Chen Y, Hauser KF (2001). Synergistic neurotoxicity of opi-oids and human immunodeficiency virus-1 Tat protein in striatal neurons in vitro. Neuroscience 102: 555–563.
   PubMed Web of Science ®Google Scholar
• Holden CP, Nath A, Haughey NJ, Geiger JD (1999). Involve-ment of Na+/H+ exchangers, Ca2+ channels, and ex-citatory amino acid receptors in intracellular Ca2+ re-sponses to HIV-1 gp120 in cultured human fetal brain cells. Neuroscience 91: 1369–1378.
   PubMed Web of Science ®Google Scholar
• Le Y, Shen W, Li B, Gong W, Dunlop NM, Wang JM (1999). A new insight into the role of "old" chemotactic peptide re-ceptors FPR and FPRL1: down-regulation of chemokine receptors CCR5 and CXCR4. Forum (Genova) 9: 299–314.
   Google Scholar
• Ma M, Nath A (1997). Molecular determinants for cellular uptake of Tat protein of human immunodeficiency virus type 1 in brain cells. J Virol 71: 2495–2499.
   PubMed Web of Science ®Google Scholar
• Mothe AJ, Brown IR (2000). Selective transport of SC1 mRNA, encoding a putative extracellular matrix glyco-protein, during postnatal development of the rat cere-bellum and retina. Brain Res Mol Brain Res 76: 73–84.
   PubMedGoogle Scholar
• Mynarcik DC, McNurlan MA, Steigbigel RT, Fuhrer J, Gelato MC (2000). Association of severe insulin resis-tance with both loss of limb fat and elevated serum tu-mor necrosis factor receptor levels in HIV lipodystrophy. J Acquir Immune Defic Syndr 25: 312–321.
   PubMed Web of Science ®Google Scholar
• Nath A (1999). Pathobiology of HIV dementia. Semin Neuro119: 113–128.
   Google Scholar
• Nath A, Conant K, Chen P, Scott C, Major EO (1999). Tran-sient exposure to HIV-1 Tat protein results in cytokine production in macrophages and astrocytes: A hit and run phenomenon. J Biol Chem 274: 17098–17102.
   PubMed Web of Science ®Google Scholar
• Nath A, Geiger JD (1998). Neurobiological Aspects of HIV infections: neurotoxic mechanisms. Prog Neurobiol 54: 19–33.
   PubMed Web of Science ®Google Scholar
• Nath A, Haughey NJ, Jones M, Anderson C, Bell JE, Geiger JD (2000a). Synergistic neurotoxicity by human immun-odeficiency virus proteins Tat and gp120: protection by memantine. Ann Neurol 47: 186–194.
   PubMed Web of Science ®Google Scholar
• Park IW, Ullrich CK, Schoenberger E, Ganju RK, Groopman JE (2001). HIV-1 tat induces microvascular endothelial apoptosis through caspase activation. J Immunol 167: 2766–2771.
   PubMed Web of Science ®Google Scholar
• Peterson PK, Molitor TW, Chao CC (1998). The opioid-cytokine connection. J Neuroimmunol 83: 63–69.
   PubMed Web of Science ®Google Scholar
• Petit F, Amoult D, Lelievre JD, Moutouh-de Parseval L, Hance AJ, Schneider P, Corbeil J, Ameisen JC, Estaquier J (2002). Productive HIV-1 infection of primary CD4+ T cells induces mitochondrial membrane permeabiliza-tion leading to a caspase-independent cell death. J Biol Chem 277: 1477–1487.
   PubMedGoogle Scholar
• Ryan LA, Zheng J, Brester M, Bohac D, Hahn F, Anderson J, Ratanasuwan W, Gendelman HE, Swindells S (2001). Plasma levels of soluble CD14 and tumor necrosis factor-alpha type II receptor correlate with cognitive dysfunc-tion during human immunodeficiency virus type 1 in-fection. J Infect Dis 184: 699–706.
   PubMed Web of Science ®Google Scholar
• Sarol LC, Imai K, Asamitsu K, Tetsuka T, Barzaga NG, Okamoto T (2002). Inhibitory effects of IFN-gamma on HIV-1 replication in latently infected cells. Biochem Bio-phys Res Commun 291: 890–896.
   Google Scholar
• Sato C, Matsuda T, Kitajima K (2002). Neuronal differentiation-dependent expression of the disialic acid epitope on C-1D166 and its involvement in neurite formation in Neuro2A cells. J Biol Chem 277: 45299–45305.
   Google Scholar
• Shen W, Proost P, Li B, Gong W, Le Y, Sargeant R, Murphy PM, Van Da=e J, Wang JM (2000). Activation of the chemotactic peptide receptor FPRL1 in monocytes phosphorylates the chemokine receptor CCR5 and atten-uates cell responses to selected chemokines. Biochem Biophys Res Commun 272: 276–283.
   PubMed Web of Science ®Google Scholar
• Shrikant P, Benos DJ, Tang LP, Benveniste EN (1996). HIV glycoprotein 120 enhances intercellular adhesion molecule-1 gene expression in glial cells. Involvement of Janus kinase/signal transducer and activator of tran-scription and protein kinase C signaling pathways. J Im-munol 156: 1307-1314.
   Google Scholar
• Su ZZ, Kang DC, Chen Y, Pekarskaya O, Chao W, Volsky DJ, Fisher PB (2002). Identification and cloning of hu-man astrocyte genes displaying elevated expression af-ter infection with HIV-1 or exposure to HIV-1 envelope glycoprotein by rapid subtraction hybridization, RaSH. Oncogene 21: 3592–3602.
   PubMed Web of Science ®Google Scholar
• Takanaga H, Ohtsuki S, Hosoya K, Terasaki T (2001). GAT2/BGT-1 as a system responsible for the transport of gamma-aminobutyric acid at the mouse blood-brain barrier. J Cereb Blood Flow Metab 21: 1232–1239.
   Google Scholar
• Tomatore C, Nath A, Amemiya K, Major EO (1991). Persis-tent HIV-1 infection in human fetal glial cells reactivated by T cell factor(s) or cytokines tumor necrosis factor-alpha and interleukin-1 beta. J Virol 65: 6094–6100.
   Google Scholar
• Vidal VF, Casteran N, Riendeau CJ, Kornfeld H, Darcissac EC, Capron A, Bahr GM (2001). Macrophage stimulation with murabutide, an HIV-suppressive muramyl pep-tide derivative, selectively activates extracellular signal-related kinases 1 and 2, C/EBPbeta and STAT1: role of CD14 and Toll-like receptors 2 and 4. Ear j Immunol 31: 1962–1971.
   Google Scholar